Matches in Wikidata for { <http://www.wikidata.org/entity/Q37308807> ?p ?o ?g. }
- Q37308807 description "2015 թվականի հունիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q37308807 description "article científic" @default.
- Q37308807 description "article scientifique" @default.
- Q37308807 description "articolo scientifico" @default.
- Q37308807 description "artigo científico" @default.
- Q37308807 description "artículu científicu espublizáu en 2015" @default.
- Q37308807 description "bilimsel makale" @default.
- Q37308807 description "scientific article published on 10 June 2015" @default.
- Q37308807 description "vedecký článok" @default.
- Q37308807 description "vetenskaplig artikel" @default.
- Q37308807 description "videnskabelig artikel" @default.
- Q37308807 description "vědecký článek" @default.
- Q37308807 description "wetenschappelijk artikel" @default.
- Q37308807 description "wissenschaftlicher Artikel" @default.
- Q37308807 description "наукова стаття, опублікована в червні 2015" @default.
- Q37308807 description "научни чланак" @default.
- Q37308807 description "مقالة علمية نشرت في 10 يونيو 2015" @default.
- Q37308807 name "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 name "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 name "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 type Item @default.
- Q37308807 label "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 label "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 label "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 prefLabel "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 prefLabel "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 prefLabel "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 P1433 Q37308807-5CBACDAE-FF2E-4190-BE95-7077B5C44F79 @default.
- Q37308807 P1476 Q37308807-3C41CD3F-4796-4056-A5C8-6DAC90634FE7 @default.
- Q37308807 P2093 Q37308807-869C1043-BF74-40AC-A8CE-E22089D6436D @default.
- Q37308807 P2093 Q37308807-870D9A4C-9111-4F2B-A27C-C38ECF37D9C5 @default.
- Q37308807 P2093 Q37308807-B663A42B-250F-4C25-8C9F-3984E8FC39C4 @default.
- Q37308807 P2093 Q37308807-BBEAC841-ED1F-4267-9051-9A2055429A50 @default.
- Q37308807 P2860 Q37308807-0404FE19-C9C7-495B-850F-CD3D735E6A43 @default.
- Q37308807 P2860 Q37308807-06555FD7-42EA-4AD9-8C2E-6F15AE790B9A @default.
- Q37308807 P2860 Q37308807-19869C6E-BB5E-4A39-BFBD-471B03621257 @default.
- Q37308807 P2860 Q37308807-1FA04C84-585D-4749-BA8D-CD34287C780A @default.
- Q37308807 P2860 Q37308807-25BC289B-19AE-42FE-8641-84F33215F164 @default.
- Q37308807 P2860 Q37308807-2968BC56-8C7E-4A73-8742-32BCE113F202 @default.
- Q37308807 P2860 Q37308807-3F9C756E-FF6B-4563-81E2-D8A6C3CFF560 @default.
- Q37308807 P2860 Q37308807-5121DAAC-3CEC-43EA-B317-73D1992D9E96 @default.
- Q37308807 P2860 Q37308807-53D2D1D3-130B-4340-A83C-7F2EF4679375 @default.
- Q37308807 P2860 Q37308807-58F5543B-062F-418C-9D70-7F4C74FFB706 @default.
- Q37308807 P2860 Q37308807-5D97109B-0384-4440-8B38-8144A7DF4B4F @default.
- Q37308807 P2860 Q37308807-630937A1-398D-4FCF-AEBB-221B4305968F @default.
- Q37308807 P2860 Q37308807-65FBB01F-A602-40A2-9113-5FC25BC879E3 @default.
- Q37308807 P2860 Q37308807-6EA34701-F061-48C1-8227-537192BE2DEF @default.
- Q37308807 P2860 Q37308807-71D51F0F-9173-48FC-8CD8-4FCC20A8DE0D @default.
- Q37308807 P2860 Q37308807-7260C2FC-70F3-4D0D-8736-83E74BB33B83 @default.
- Q37308807 P2860 Q37308807-75703566-8769-409B-A286-0734F15E588A @default.
- Q37308807 P2860 Q37308807-758C821C-FB8B-4CA0-AC7A-D688F297B993 @default.
- Q37308807 P2860 Q37308807-7AC5C967-F985-41F1-8047-06D95E642D10 @default.
- Q37308807 P2860 Q37308807-7AFBAB97-F8E4-4C75-B75C-9306B6149C40 @default.
- Q37308807 P2860 Q37308807-863BCF0B-370E-4836-9BA9-39638C0B6798 @default.
- Q37308807 P2860 Q37308807-87C48094-4F39-4D21-8F56-7A5363B6C321 @default.
- Q37308807 P2860 Q37308807-97D37BE8-0C45-4390-B764-F36271CE733F @default.
- Q37308807 P2860 Q37308807-9FC1BF95-E2F5-43C6-9CBB-78CC4E94FF2C @default.
- Q37308807 P2860 Q37308807-A105A3A8-C0A1-4C93-821F-39E3919592ED @default.
- Q37308807 P2860 Q37308807-A6713E4D-2600-4899-AE7D-FAD873709C8B @default.
- Q37308807 P2860 Q37308807-ACCD8794-4C32-441E-99BF-2E31F31813A5 @default.
- Q37308807 P2860 Q37308807-AECD2960-42EC-4A30-8FD4-F4FE6B12169B @default.
- Q37308807 P2860 Q37308807-B9B6483C-0963-4C4B-99C1-623F39C88ACC @default.
- Q37308807 P2860 Q37308807-BAECD7AF-3F88-408C-BCAE-815F5A8C3E88 @default.
- Q37308807 P2860 Q37308807-D3159491-D7B5-4ECE-A888-72A245178379 @default.
- Q37308807 P2860 Q37308807-D8343545-3F4C-452B-BD30-A9F0E9F9B6BD @default.
- Q37308807 P2860 Q37308807-F18CA832-1A88-43F4-B322-E970105A02EA @default.
- Q37308807 P2860 Q37308807-F328904C-8AB4-4E3B-9967-AFCB1D78A4CD @default.
- Q37308807 P2860 Q37308807-FAB6BF7D-E11F-4146-99B2-7B9A898F9F21 @default.
- Q37308807 P2860 Q37308807-FCD4C0B6-6077-4505-A76F-D8489DBD4ED6 @default.
- Q37308807 P304 Q37308807-F7C2C67F-1140-4569-8901-D4CD08888458 @default.
- Q37308807 P31 Q37308807-844F9FCB-AFF1-4118-9491-497321CD29A7 @default.
- Q37308807 P356 Q37308807-6D2C7A33-8E4A-4EE6-B948-CDC3C948ACBF @default.
- Q37308807 P433 Q37308807-B596A661-5652-458C-9EA8-D0EB2B5269E4 @default.
- Q37308807 P478 Q37308807-C1B89EF8-A89E-4E75-92D9-9201192A551A @default.
- Q37308807 P577 Q37308807-44D186AE-85D6-45F5-8845-B477E37803CD @default.
- Q37308807 P5875 Q37308807-70A23272-13C9-48B2-B294-5DB722140D86 @default.
- Q37308807 P698 Q37308807-C619C088-C238-4D07-8974-EC84372283E2 @default.
- Q37308807 P921 Q37308807-3AB4D006-9B96-4B89-B6B2-CE802A452575 @default.
- Q37308807 P921 Q37308807-5C3A69C8-F798-4A34-B33B-EB9D81746E34 @default.
- Q37308807 P921 Q37308807-F12E7B44-63A5-4BB2-ABB8-CDBCE9B9CE8F @default.
- Q37308807 P932 Q37308807-1CD2ADBF-0A10-4395-BB72-A1C6673B7DE6 @default.
- Q37308807 P356 JCPH.566 @default.
- Q37308807 P698 26096377 @default.
- Q37308807 P1433 Q7743562 @default.
- Q37308807 P1476 "Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia" @default.
- Q37308807 P2093 "Alan J Xiao" @default.
- Q37308807 P2093 "Benjamin W Miller" @default.
- Q37308807 P2093 "David P Nicolau" @default.
- Q37308807 P2093 "Jennifer A Huntington" @default.
- Q37308807 P2860 Q22241905 @default.
- Q37308807 P2860 Q33342625 @default.
- Q37308807 P2860 Q33747920 @default.
- Q37308807 P2860 Q34057425 @default.
- Q37308807 P2860 Q34216623 @default.
- Q37308807 P2860 Q34299064 @default.
- Q37308807 P2860 Q34307105 @default.
- Q37308807 P2860 Q34320027 @default.
- Q37308807 P2860 Q34737703 @default.
- Q37308807 P2860 Q35004269 @default.
- Q37308807 P2860 Q35545954 @default.